Lv0
0 积分 2024-07-12 加入
Izalontamab brengitecan, an EGFR and HER3 bispecific antibody–drug conjugate, versus chemotherapy in heavily pretreated recurrent or metastatic nasopharyngeal carcinoma: a multicentre, randomised, open-label, phase 3 study in China
2天前
已完结
Characteristics of Diabetes Patients with Inadequately Controlled Hypertension: Insights from the EnligHTN Study
1个月前
已关闭
皖公网安备34019202002308
